SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001829126-23-001528
Filing Date
2023-02-14
Accepted
2023-02-14 16:33:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D/A organicellregen_sc13da.htm SC 13D/A 62819
3 GRAPHIC corresp_001.jpg GRAPHIC 53872
4 filename4.htm CORRESP 7109
  Complete submission text file 0001829126-23-001528.txt   146062
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Organicell Regenerative Medicine, Inc. (Subject) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: SC 13D/A | Act: 34 | File No.: 005-87575 | Film No.: 23630323
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1930 HARRISON STREET SUITE 204 HOLLYWOOD FL 33020
Business Address 1930 HARRISON STREET SUITE 204 HOLLYWOOD FL 33020 954-701-4123
Skycrest Holdings, LLC (Filed by) CIK: 0001952164 (see all company filings)

IRS No.: 980594973
Type: SC 13D/A